Estrella Immunopharma, Inc. Share Price

Estrella Immunopharma, Inc. Share Price

NASDAQ: ESLA | Micro Cap
$0.65
-$0.09 (-11.89%) Last updated on 31 Oct, 2026 | 01:23 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Estrella Immunopharma, Inc. Stock Performance

Open
$0.73
Prev. Close
$0.74
Circuit Range
N/A
Day Range
$0.65 - $0.73
Year Range
$0.27 - $3.08
Volume
1,550
Average Traded
$0.69

Estrella Immunopharma, Inc. Share Price Today

As of 31 October 2026, Estrella Immunopharma, Inc.'s share price is $0.65. The stock opened at $0.73, compared to its previous close of $0.74. During today's trading session, Estrella Immunopharma, Inc.'s share price traded between $0.65 and $0.73, with an average price of $0.69. Over the past 52 weeks, the stock has recorded a high of $3.08 and a low of $0.27. In terms of performance, Estrella Immunopharma, Inc.'s share price has declined by 59.93% over the last six months and is down 72.81% on a year-on-year basis.

Estrella Immunopharma, Inc. Share Price Chart

Line chart of the Estrella Immunopharma, Inc. price trend over the selected period. The price fell overall, ranging from 0.65 to 0.73, ending at 0.65.
$0.65$0.73
L
Show Current Price
H

Estrella Immunopharma, Inc. Stock Fundamentals & Key Indicators

Market Cap
$23.97M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.23
Revenue (TTM)
$0.00
Return On Equity (TTM)
134.74%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
51.87%

Estrella Immunopharma, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$4.80-$0.61-$2.29-$2.31
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A87.29%-275.41%-0.87%

Estrella Immunopharma, Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$7.31-$13.06
Net Profit MarginN/AN/A
Income ChangeN/A-78.66%

About Estrella Immunopharma, Inc.

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.

Estrella Immunopharma, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$0.41
$0.65
+41.52%
Sep 2026
$0.70
$0.46
-37.75%
Aug 2026
$0.74
$0.74
-0.14%
Jul 2026
$0.95
$0.74
-24.87%
Jun 2026
$1.11
$0.98
-12.05%
May 2026
$1.67
$1.12
-31.08%
Apr 2026
$1.02
$1.63
+56.25%
Mar 2026
$1.10
$1.04
-14.05%
Feb 2026
$1.13
$1.21
+8.04%
Jan 2026
$1.48
$1.12
-27.27%
Dec 2025
$2.05
$1.54
-27.36%
Nov 2025
$2.46
$2.12
-11.48%

ESLA Share Price FAQs